The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.

Duchenne muscular dystrophy (DMD) is an X-linked recessive muscle wasting disease caused by the absence of a muscle cytoskeletal protein, dystrophin. Utrophin is the autosomal homologue of dystrophin. We previously demonstrated that overexpression of utrophin in the muscles of dystrophin-null transgenic mice completely prevented the phenotype arising from dystrophin deficiency. Two independently regulated promoters control utrophin expression and the upstream promoter (promoter A) is synaptically regulated in muscle. In this study, we have investigated basal regulation and myogenic induction of promoter A. Interactions between Ap2 and Sp1 and their cognate DNA motifs are critical for basal transcription from the minimal promoter region. During differentiation of C2C12 myoblasts in vitro, a 2-fold increase in A-utrophin mRNA level was observed. Expression of a reporter gene, whose transcription was driven by a 1.3 kb promoter A fragment, paralleled expression of the endogenous transcript. Myogenic induction mapped to a conserved upstream muscle-specific E-box, which was shown to bind myogenic regulatory factors, transactivating the promoter up to 18-fold in transient assays. This study provides a basis for further understanding the regulatory mechanisms that control utrophin expression in muscle and may facilitate the development of reagents to effect therapeutic up-regulation of utrophin in DMD.

[1]  K. Davies,et al.  A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Hauschka,et al.  A Novel Site in the Muscle Creatine Kinase Enhancer Is Required for Expression in Skeletal but Not Cardiac Muscle (*) , 1996, The Journal of Biological Chemistry.

[3]  B. Wold,et al.  Herculin, a fourth member of the MyoD family of myogenic regulatory genes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Davies,et al.  Expression of the dystrophin‐related protein (utrophin) gene during mouse embryogenesis , 1993, Developmental dynamics : an official publication of the American Association of Anatomists.

[5]  H. Arnold,et al.  Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis. , 1991, The New biologist.

[6]  S. Hauschka,et al.  Muscle Gene E-box Control Elements , 1995, The Journal of Biological Chemistry.

[7]  K. Davies,et al.  Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene , 1996, Nature.

[8]  D. Lockshon,et al.  MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer , 1989, Cell.

[9]  E. Olson,et al.  Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Davies,et al.  Dystrophin and dystrophin-related proteins: A review of protein and RNA studies , 1993, Neuromuscular Disorders.

[11]  S. Hirai,et al.  Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects , 1993, Journal of the Neurological Sciences.

[12]  P. Gardner,et al.  Sp1 and Sp3 Regulate Expression of the Neuronal Nicotinic Acetylcholine Receptor β4 Subunit Gene* , 1997, The Journal of Biological Chemistry.

[13]  S. Hauschka,et al.  EVIDENCE FOR QUANTITATIVELY DIFFERENT TRANSCRIPTIONAL ACTIVITIES AND THE BINDING OF DISTINCT REGULATORY FACTORS , 1995 .

[14]  P. Taylor,et al.  Promoter elements and transcriptional control of the mouse acetylcholinesterase gene. , 1993, The Journal of biological chemistry.

[15]  H. Haugen,et al.  Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice , 1996, Molecular and cellular biology.

[16]  S. Oliviero,et al.  Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter. , 2001, Journal of molecular biology.

[17]  K. Davies,et al.  The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies , 1992, Neuromuscular Disorders.

[18]  K. Luskey.  Conservation of promoter sequence but not complex intron splicing pattern in human and hamster genes for 3-hydroxy-3-methylglutaryl coenzyme A reductase , 1987, Molecular and cellular biology.

[19]  K. Davies,et al.  Utrophin: A potential replacement for dystrophin? , 1993, Neuromuscular Disorders.

[20]  A. Mutero,et al.  Transcription Factor Repression and Activation of the Human Acetylcholinesterase Gene (*) , 1995, The Journal of Biological Chemistry.

[21]  H. Haugen,et al.  E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice , 1996, Molecular and cellular biology.

[22]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[23]  J. Ervasti,et al.  Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle , 1991, Neuron.

[24]  L. Kedes,et al.  Differences between MyoD DNA binding and activation site requirements revealed by functional random sequence selection , 1996, Molecular and cellular biology.

[25]  Simon C Watkins,et al.  Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle , 1991, Neuromuscular Disorders.

[26]  J. Changeux,et al.  Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Gramolini,et al.  Expression of the utrophin gene during myogenic differentiation. , 1999, Nucleic acids research.

[28]  J. Brunet,et al.  Noradrenergic-Specific Transcription of the Dopamine β-Hydroxylase Gene Requires Synergy of MultipleCis-Acting Elements Including at Least Two Phox2a-Binding Sites , 1998, The Journal of Neuroscience.

[29]  J. Léger,et al.  Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency? , 1994, Journal of the Neurological Sciences.

[30]  J. Schmidt,et al.  Interaction of MyoD Family Proteins with Enhancers of Acetylcholine Receptor Subunit Genes in Vivo * , 2000, The Journal of Biological Chemistry.

[31]  J. Saffer,et al.  Developmental expression of Sp1 in the mouse , 1991, Molecular and cellular biology.

[32]  J. Changeux,et al.  Localization of dystrophin and dystrophin-related protein at the electromotor synapse and neuromuscular junction in Torpedo marmorata , 1992, Neuroscience.

[33]  J. Ervasti,et al.  Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle , 1992, Nature.

[34]  Susan C. Brown,et al.  Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy , 1997, Cell.

[35]  A. Gramolini,et al.  Muscle and Neural Isoforms of Agrin Increase Utrophin Expression in Cultured Myotubes via a Transcriptional Regulatory Mechanism* , 1998, The Journal of Biological Chemistry.

[36]  K. Davies,et al.  Molecular and functional analysis of the utrophin promoter. , 1996, Nucleic acids research.

[37]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[38]  L. Kedes,et al.  Myogenic Basic Helix-Loop-Helix Proteins and Sp1 Interact as Components of a Multiprotein Transcriptional Complex Required for Activity of the Human Cardiac α-Actin Promoter , 1999, Molecular and Cellular Biology.